The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis

  title={The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis},
  author={Joseph Firth and B. Stubbs and Jerome Sarris and Simon Rosenbaum and Scott B. Teasdale and Michael Berk and Alison Ruth Yung},
  journal={Psychological Medicine},
  pages={1515 - 1527}
Background When used as an adjunctive with antipsychotics, certain vitamins and minerals may be effective for improving symptomatic outcomes of schizophrenia, by restoring nutritional deficits, reducing oxidative stress, or modulating neurological pathways. Method We conducted a systematic review of all randomized controlled trials (RCTs) reporting effects of vitamin and/or mineral supplements on psychiatric symptoms in people with schizophrenia. Random-effects meta-analyses were used to… 

Multinutrients for the Treatment of Psychiatric Symptoms in Clinical Samples: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

This review highlights the need for robust methodology-RCTs that report full data, including means and standard deviations for all outcomes-in order to further elucidate the effects of multinutrients for psychiatric symptoms.

Adjunctive folate for major mental disorders: A systematic review.

Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis

Deficits in vitamin D and folate previously observed in long-term schizophrenia appear to exist from illness onset, and are associated with worse symptomology.

The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials

  • J. FirthS. Teasdale J. Sarris
  • Psychology, Medicine
    World psychiatry : official journal of the World Psychiatric Association
  • 2019
Clinicians should be informed of the nutrient supplements with established efficacy for certain conditions (such as eicosapentaenoic acid in depression), but also made aware of those currently lacking evidentiary support, to further elucidate the underlying mechanisms.

Nutritional supplements in psychotic disorders.

It is hoped that the initiation of personalized medicine strategies, such as stratification and using a clinical staging approach, will make it possible to identify the subgroups of patients who can obtain maximum benefit from dietary and nutritional interventions.

Nutritional psychiatry: the present state of the evidence

Preliminary clinical evidence that dietary interventions in clinically diagnosed populations are feasible and can provide significant clinical benefit is provided, and nutraceuticals including n-3 fatty acids, folate, S-adenosylmethionine, N-acetyl cysteine and probiotics are promising avenues for future research.



Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia.

Folate plus vitamin B12 supplementation can improve negative symptoms of schizophrenia, but treatment response is influenced by genetic variation in folate absorption, which supports a personalized medicine approach for the treatment of negative symptoms.

Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses.

Current evidence supports adjunctive use of SAMe, methylfolate, omega-3, and vitamin D with antidepressants to reduce depressive symptoms.

Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies.

A systematic review and meta-analysis of observational studies found a strong association between vitamin D deficiency and schizophrenia, however, randomized clinical trials are required to confirm the findings.

Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review

Despite positive preliminary findings, there are less data available to support efficacy of micronutrient formulas in treating bipolar disorder, attention deficit-hyperactivity disorder and substance abuse/dependence and no clinical trials have been done with clinically depressed or anxious patient samples, psychosis or eating disorders.

Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia

Oral supplementation of vitamin C with atypical antipsychotic reverses ascorbic acid levels, reduces oxidative stress, and improves BPRS score, hence both the drugs in combination can be used in the treatment of schizophrenia.

Eicosapentaenoic Acid Interventions in Schizophrenia: Meta-Analysis of Randomized, Placebo-Controlled Studies

Meta-analysis of randomized controlled trials on symptomatic outcome revealed no beneficial effect of EPA augmentation in established schizophrenia, and no conclusion can be made for medium- to long-term effects of EPA in schizophrenia, in particular on relapse prevention in the early course of psychotic disorders.

Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled study.

The aim of this study was to examine whether vitamin B6 therapy influences psychotic symptoms in patients suffering from schizophrenia and schizoaffective disorder, and to clarify the question of the possible efficacy of vitamin B 6 in treatment of psychotic Symptoms in schizophrenia.

Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review

It is suggested that a personalised approach to schizophrenia warrants research attention as there is growing agreement that schizophrenia is a spectrum disorder that develops from the interplay between environmental and genetic factors.

Vitamin–mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial

Preliminary evidence of efficacy for micronutrients in the treatment of ADHD symptoms in adults, with a reassuring safety profile is provided.